Inflammatory bowel disease (IBD)-associated gut dysbiosis is characterized by a reduction in number and activity of protective gut commensals involved in the production of short-chain fatty acids, secondary bile acids and indole-based aryl-hydrocarbon receptor ligands [4–6]. This evidence concerns the gene AHR and inflammatory bowel disease.